XML 53 R37.htm IDEA: XBRL DOCUMENT v3.25.2
EQUITY COMPENSATION PLAN - Narrative (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
shares
Dec. 31, 2024
shares
May 30, 2024
right
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Aggregate intrinsic value of stock options exercised | $     $ 65,300,000    
Total fair value of stock options | $     42,500,000    
Merger consideration exercise price (in dollars per share) | $ / shares         $ 35.00
Sale of stock, per share in cash (in dollars per share) | $ / shares         $ 30.00
Sale of stock, right per share, contingency | right         1
Sale of stock, price per share, contingency (in dollars per share) | $ / shares         $ 5.00
Cancelled, threshold exercise price (in dollars per share) | $ / shares         $ 35.00
Stock-based compensation expense | $   $ 5,220,000 $ 52,571,000    
2017 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based compensation arrangement by Share-based payment award, options, outstanding, number (in shares) | shares         0
Granted (in shares) | shares   0 0    
Stock-based compensation expense | $   $ 0      
Unrecognized stock-based compensation expense | $ $ 0 0      
2024 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total fair value of stock options | $   $ 11,900,000 $ 0    
Share-based compensation arrangement by Share-based payment award, options, outstanding, number (in shares) | shares 3,647,000 3,647,000   3,660,000  
Granted (in shares) | shares   271,000      
Unrecognized stock-based compensation expense | $ $ 30,400,000 $ 30,400,000      
Number of shares authorized (in shares) | shares 4,000,000.0 4,000,000.0      
Number of shares authorized, currently available (in shares) | shares 400,000 400,000      
Stock options exercised (in shares) | shares   0 0    
Weighted-average period of recognition (in years) 2 years 10 months 24 days        
Options to purchase common stock issued and outstanding | 2017 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   4 years      
Contractual term (in years)   10 years      
Options to purchase common stock issued and outstanding | 2017 Plan | Cliff Vesting          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   1 year      
Options to purchase common stock issued and outstanding | 2024 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Contractual term (in years)   10 years      
Options to purchase common stock issued and outstanding | 2024 Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   4 years      
Options to purchase common stock issued and outstanding | 2024 Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years)   1 year